Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Double-Unit Cord Blood Transplantation for Hematological Malignancies in Japan: Multicenter Phase II Study (C-SHOT 0507)

Atsushi Wake, MD, PhD, Shunro Kai, MD. PhD, Masaya Okada, MD, PhD, Mio Kurata, Yoshiko Atsuta, MD, Jun Ishikawa, MD, Masayuki Hino, M.D., Ph.D., Nobuyuki Aotsuka, MD, PhD, Masaharu Kasai, MD, PhD, Mahito Misawa, MD, PhD, Shuichi Taniguchi, MD, PhD, Shunichi Kato, MD, PhD

Blood (2011) 118 (21): 3071.

https://doi.org/10.1182/blood.V118.21.3071.3071

Published: 2011

Journal Articles

Phase II Study of Chemotherapy (Cx) and Stem Cell Transplantation (SCT) for Adult Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma (LBL): Long-Term Follow-up Results of Japan Clinical Oncology Group (JCOG) Study 9402.

Teruhisa Azuma, MD, Kensei Tobinai, MD, PhD, Kunihiko Takeyama, MD, PhD, Taro Shibata, MSc, Haruhiko Fukuda, MD, PhD, Fumio Kawano, MD, PhD, Keiko Aikawa, MD, PhD, Masaharu Kasai, MD, PhD, Takaaki Chou, MD, PhD, Masayuki Sano, MD, PhD, Kuniaki Itoh, MD, PhD, Toshiaki Sai, MD, PhD, Hisashi Yamada, MD, PhD, Kiyoshi Mukai, MD, PhD, Tomomitsu Hotta, MD, PhD, Masanori Shimoyama, MD, PhD

Blood (2009) 114 (22): 3087.

https://doi.org/10.1182/blood.V114.22.3087.3087

Published: 2009

Journal Articles

Pre-Treatment Serum Soluble Interleukin-2 Receptor Value Significantly Predicts Survival in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma.

Shinsuke Noguchi, MD, Masanobu Nakata, MD, Kanako Shima, MD, Yuki Katsura, MD, Toshihiro Matsukawa, MD, Minoru Kanaya, MD, Satomi Matsuoka, MD, Mizuha Kosugi, MD, Shiro Fujii, MD, Shuichi Ota, MD, PhD, Kiyotoshi Imai, MD, PhD, Teiichi Hirano, MD, PhD, Naoki Kobayashi, MD, PhD, Masahiro Ogasawara, MD, PhD, Yoshio Kiyama, MD, Masaharu Kasai, MD, PhD

Blood (2009) 114 (22): 3948.

https://doi.org/10.1182/blood.V114.22.3948.3948

Published: 2009

Journal Articles

Imatinib Mesylate Impairs the Function of Human Regulatory T Cells (Tregs) and Reverses the Inhibition of Immune Responses to Imatinib-Resistant CML Cells by Tregs.

Masahiro Ogasawara, Toshihiro Matsukawa, Yuki Katsura, Kanako Shima, Minoru Kanaya, Mizuha Kosugi, Satomi Matsuoka, Shiro Fujii, Shinsuke Noguchi, Shuichi Ota, MD, PhD, Masanobu Nakata, MD, Kiyotoshi Imai, Teiichi Hirano, Naoki Kobayashi, Yoshio Kiyama, MD, Masaharu Kasai, MD, PhD

Blood (2009) 114 (22): 4728.

https://doi.org/10.1182/blood.V114.22.4728.4728

Published: 2009

Journal Articles

Hematopoietic stem cell transplantation for core binding factor acute myeloid leukemia: t(8;21) and inv(16) represent different clinical outcomes

Yachiyo Kuwatsuka, Koichi Miyamura, Ritsuro Suzuki, Masaharu Kasai, Atsuo Maruta, Hiroyasu Ogawa, Ryuji Tanosaki, Satoshi Takahashi, Kyuhei Koda, Kazuhiro Yago, Yoshiko Atsuta, Takashi Yoshida, Hisashi Sakamaki, Yoshihisa Kodera

Blood (2009) 113 (9): 2096–2103.

https://doi.org/10.1182/blood-2008-03-145862

Published: 2009

Includes: Supplemental data

Journal Articles

Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia

Yoshiko Atsuta, Ritsuro Suzuki, Tokiko Nagamura-Inoue, Shuichi Taniguchi, Satoshi Takahashi, Shunro Kai, Hisashi Sakamaki, Yasushi Kouzai, Masaharu Kasai, Takahiro Fukuda, Hiroshi Azuma, Minoko Takanashi, Shinichiro Okamoto, Masahiro Tsuchida, Keisei Kawa, Yasuo Morishima, Yoshihisa Kodera, Shunichi Kato, for the Japan Marrow Donor Program and the Japan Cord Blood Bank Network

Blood (2009) 113 (8): 1631–1638.

https://doi.org/10.1182/blood-2008-03-147041

Published: 2009

Includes: Supplemental data

Journal Articles

Phase II Study of Rituximab Combined with Cladribine and Mitoxantrone in Relapsed or Refractory Indolent Non-Hodgkin’s Lymphoma

Shuichi Ota, MD, Junji Tanaka, MD, Masanobu Nakata, MD, Kiyotoshi Imai, MD, Masahiro Ogasawara, MD, Yoshio Kiyama, MD, Tatsuro Irie, MD, Masanobu Morioka, MD, Shintaro Umehara, MD, Hiroshi Iwasaki, MD, Koji Chiba, MD, Yasutaka Kakinoki, MD, Takashi Fukuhara, MD, Masaharu Kasai, MD, Masahiro Imamura, MD

Blood (2008) 112 (11): 4946.

https://doi.org/10.1182/blood.V112.11.4946.4946

Published: 2008

Journal Articles

The Influence of Cytochrome P450 3A Gene Polymorphisms on Tacrolimus Concentrations in Hematopoetic Stem Cell Transplantation Patients.

Masahiro Ogasawara, Mizuha Kosugi, Satomi Matsuoka, Shinsuke Asamuma, Shinsuke Noguchi, Sirou Fujii, Akinori Wada, Shuichi Ota, Masanobu Nakata, Kiyotoshi Imai, Naoki Kobayashi, Yoshio Kiyama, Masaharu Kasai

Blood (2008) 112 (11): 2230.

https://doi.org/10.1182/blood.V112.11.2230.2230

Published: 2008

Journal Articles

Similar Background of Graft-Versus-Host Disease (GVHD) Following Allogeneic Blood and Marrow Transplantation (Tx) in Korean and Japanese Populations Allows a Uniform Foundation To Perform Large-Scale Clinical Studies in the Region.

Blood (2007) 110 (11): 5007.

https://doi.org/10.1182/blood.V110.11.5007.5007

Published: 2007

Journal Articles

Low Serum Total Protein and Unfavorable Pathological Subtype Are Independent Unfavorable Factors in Peripheral T-Cell Lymphoma (PTCL) Treated in Prospective Clinical Tirals; Japan Clinical Oncology Group (JCOG) 0108A Study.

Yoshitoyo Kagami, MD, Tomohiro Kinoshita, MD, Takashi Watanabe, MD, Kuniaki Itoh, MD, Harumi Kaba, MSc, Kenichi Yoshimura, PhD, Motoko Yamaguchi, MD, Mitsutoshi Kurosawa, MD, Kunihiro Tsukasaki, MD, Masaharu Kasai, MD, Kensei Tobinai, MD, Yoshihiro Matsuno, MD, Kiyoshi Mukai, MD, Tomomitsu Hotta, MD, Masanori Shimoyama, MD

Blood (2007) 110 (11): 3450.

https://doi.org/10.1182/blood.V110.11.3450.3450

Published: 2007

Journal Articles

Large Scale Expansion of Human Dendritic Cells with Regulatory Function from Peripheral Blood Monocytes Employing Leukapheresis and Rapamycin for Clinical Trials.

Masahiro Ogasawara, MD, PhD, Shinsuke Asanuma, MD, Shinsuke Noguchi, MD, Atsushi Yasumoto, MD, Akinori Wada, MD, Shuuichi Ohta, MD, PhD, Masanobu Nakata, MD, Kiyotoshi Imai, MD, PhD, Teiichi Hirano, MD, PhD, Naoki Kobayashi, MD, PhD, Yoshio Kiyama, MD, Junji Tanaka, MD, PhD, Masahiro Imamura, MD, PhD, Masaharu Kasai, MD, PhD

Blood (2007) 110 (11): 1204.

https://doi.org/10.1182/blood.V110.11.1204.1204

Published: 2007

Journal Articles

Induction of Survivin-Specific, HLA-A24 Restricted Cytotoxic T Lymphocytes Using an Immunodominant Peptide; In-Vitro Feasibility Study and a Clinical Trial of Survivin Peptide Vaccination.

Masahiro Ogasawara, MD, PhD, Misato Kikuchi, MD, PhD, Satoru Kimura, MD, PhD, Koichiro Kobayashi, MD, PhD, Takayoshi Miyazono, MD, PhD, Masanobu Nakata, MD, PhD, Kiyotoshi Imai, MD, PhD, Teiichi Hirano, MD, PhD, Naoki Kobayashi, MD, PhD, Yoshio Kiyama, MD, PhD, Junji Tanaka, MD, PhD, Masahiro Imamura, MD, PhD, Masaharu Kasai, MD, PhD

Blood (2006) 108 (11): 2709.

https://doi.org/10.1182/blood.V108.11.2709.2709

Published: 2006

Journal Articles

Feasibility of Reduced-Intensity Cord Blood Transplantation (RICBT) as a Salvage Therapy for Graft Failure (GF): Results of a Nationwide Survey of 63 Patients.

Blood (2006) 108 (11): 3114.

https://doi.org/10.1182/blood.V108.11.3114.3114

Published: 2006

Journal Articles

Tacrolimus Concentrations in Hematopoetic Stem Cell Transplantation Patients Are Related to Cytochrome P450 3A5 Gene Polymorphisms.

Koichiro Kobayashi, MD, PhD, Masahiro Ogasawara, MD, PhD, Misato Kikuchi, MD, PhD, Satoru Kimura, MD, PhD, Takayoshi Miyazono, MD, PhD, Masanobu Nakata, MD, PhD, Kiyotoshi Imai, MD, PhD, Teiichi Hirano, MD, PhD, Naoki Kobayashi, MD, PhD, Yoshio Kiyama, MD, PhD, Junji Tanaka, MD, PhD, Masahiro Imamura, MD, PhD, Mitsune Tanimoto, MD, PhD, Masaharu Kasai, MD, PhD

Blood (2006) 108 (11): 2902.

https://doi.org/10.1182/blood.V108.11.2902.2902

Published: 2006

Journal Articles

Peripheral T-Cell Lymphoma-Unspecified (PTCL-U) and NK/T-Cell Lymphoma Showed a Significantly Poor Prognosis in a Randomized Controlled Trial (RCT) JCOG9002 with Multidrug Combination Chemotherapy for Aggressive Lymphoma.

Tomohiro Kinoshita, MD, Tomomitsu Hotta, MD, Taro Shibata, MSc, Kiyoshi Mukai, MD, Motoko Yamaguchi, MD, Kunihiro Tsukasaki, MD, Yoshitoyo Kagami, MD, Masaharu Kasai, MD, Kensei Tobinai, MD, Masanori Shimoyama, MD

Blood (2006) 108 (11): 2465.

https://doi.org/10.1182/blood.V108.11.2465.2465

Published: 2006

Journal Articles

Myeloablative allogeneic hematopoietic stem cell transplantation for non-Hodgkin lymphoma: a nationwide survey in Japan

Blood (2006) 108 (1): 382–389.

https://doi.org/10.1182/blood-2005-02-0596

Published: 2006

Journal Articles

Unrelated Donor Marrow Transplantation for Acute Lymphoblastic Leukemia in Japan. A Japan Marrow Donor Program Experience between 1993 and 2003.

Masahiro Tsuchida, MD, Hiroshi Sao, MD, Hisashi Sakamaki, MD, Keisei Kawa, MD, Yoshinobu Kanda, MD, Koji Kato, MD, Masamichi Hara, MD, Mutsuo Ishii, MD, Akira Kikuchi, MD, Jun Okamura, MD, Atsuo Maruta, MD, Yoichi Takaue, MD, Masaharu Kasai, MD, Hiromasa Yabe, MD, Yasuo Morishima, MD, Shunichi Kato, MD, Yoshihisa Kodera, MD

Blood (2005) 106 (11): 442.

https://doi.org/10.1182/blood.V106.11.442.442

Published: 2005

Journal Articles

Effect of Granulocytes Colony Stimulating Factor on Decreased IL-12 p40 Production by Chemotherapy.

Tomomi Toubai, Junji Tanaka, Shuichi Ota, Takashi Fukuhara, Satoshi Hashino, Takeshi Kondo, Masanobu Morioka, Tsugumichi Kawamura, Nobuo Masauzi, Yasutaka Kakinoki, Hajime Kobayashi, Yasuyuki Kunieda, Masaharu Kasai, Mitsutoshi Kurosawa, Masahiro Imamura

Blood (2004) 104 (11): 4550.

https://doi.org/10.1182/blood.V104.11.4550.4550

Published: 2004

Journal Articles

CCL19 and CCL21 Chemokines Induce Endocytosis and Augment Antigen Presentation in Human Mature Dendritic Cells.

Masahiro Ogasawara, MD, PhD, Junji Tanaka, MD, PhD, Masahiro Imamura, MD, PhD, Masaharu Kasai, MD, PhD

Blood (2004) 104 (11): 2651.

https://doi.org/10.1182/blood.V104.11.2651.2651

Published: 2004

Journal Articles

Role of Chemotherapy before Allogeneic Stem Cell Transplantation (ALLO-SCT) from an HLA-Identical Sibling Donor for Myelodysplastic Syndrome (MDS).

Kunihisa Nakai, Yoshinobu Kanda, Shirou Fukuhara, Hisashi Sakamaki, Shinichiro Okamoto, Yoshihisa Kodera, Ryuji Tanosaki, Satoshi Takahashi, Takafumi Matsushima, Yoshiko Atsuta, Nobuyuki Hamajima, Masaharu Kasai, Shunichi Kato

Blood (2004) 104 (11): 5126.

https://doi.org/10.1182/blood.V104.11.5126.5126

Published: 2004

NARROW

Double-Unit Cord Blood Transplantation for Hematological Malignancies in Japan: Multicenter Phase II Study (C-SHOT 0507)

Phase II Study of Chemotherapy (Cx) and Stem Cell Transplantation (SCT) for Adult Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma (LBL): Long-Term Follow-up Results of Japan Clinical Oncology Group (JCOG) Study 9402.

Pre-Treatment Serum Soluble Interleukin-2 Receptor Value Significantly Predicts Survival in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma.

Imatinib Mesylate Impairs the Function of Human Regulatory T Cells (Tregs) and Reverses the Inhibition of Immune Responses to Imatinib-Resistant CML Cells by Tregs.

Hematopoietic stem cell transplantation for core binding factor acute myeloid leukemia: t(8;21) and inv(16) represent different clinical outcomes

Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia

Phase II Study of Rituximab Combined with Cladribine and Mitoxantrone in Relapsed or Refractory Indolent Non-Hodgkin’s Lymphoma

The Influence of Cytochrome P450 3A Gene Polymorphisms on Tacrolimus Concentrations in Hematopoetic Stem Cell Transplantation Patients.

Similar Background of Graft-Versus-Host Disease (GVHD) Following Allogeneic Blood and Marrow Transplantation (Tx) in Korean and Japanese Populations Allows a Uniform Foundation To Perform Large-Scale Clinical Studies in the Region.

Low Serum Total Protein and Unfavorable Pathological Subtype Are Independent Unfavorable Factors in Peripheral T-Cell Lymphoma (PTCL) Treated in Prospective Clinical Tirals; Japan Clinical Oncology Group (JCOG) 0108A Study.

Large Scale Expansion of Human Dendritic Cells with Regulatory Function from Peripheral Blood Monocytes Employing Leukapheresis and Rapamycin for Clinical Trials.

Induction of Survivin-Specific, HLA-A24 Restricted Cytotoxic T Lymphocytes Using an Immunodominant Peptide; In-Vitro Feasibility Study and a Clinical Trial of Survivin Peptide Vaccination.

Feasibility of Reduced-Intensity Cord Blood Transplantation (RICBT) as a Salvage Therapy for Graft Failure (GF): Results of a Nationwide Survey of 63 Patients.

Tacrolimus Concentrations in Hematopoetic Stem Cell Transplantation Patients Are Related to Cytochrome P450 3A5 Gene Polymorphisms.

Peripheral T-Cell Lymphoma-Unspecified (PTCL-U) and NK/T-Cell Lymphoma Showed a Significantly Poor Prognosis in a Randomized Controlled Trial (RCT) JCOG9002 with Multidrug Combination Chemotherapy for Aggressive Lymphoma.

Myeloablative allogeneic hematopoietic stem cell transplantation for non-Hodgkin lymphoma: a nationwide survey in Japan

Unrelated Donor Marrow Transplantation for Acute Lymphoblastic Leukemia in Japan. A Japan Marrow Donor Program Experience between 1993 and 2003.

Effect of Granulocytes Colony Stimulating Factor on Decreased IL-12 p40 Production by Chemotherapy.

CCL19 and CCL21 Chemokines Induce Endocytosis and Augment Antigen Presentation in Human Mature Dendritic Cells.

Role of Chemotherapy before Allogeneic Stem Cell Transplantation (ALLO-SCT) from an HLA-Identical Sibling Donor for Myelodysplastic Syndrome (MDS).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only